Market Tracker

07/22 2:48pm ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

8.02
Real-Time Quote
 -0.25 / -3.02%
Today’s Change
1.68
Today|||52-Week Range
9.56
+218.25%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close8.27
Today’s open8.28
Day’s range8.12 - 8.40
Volume144,397
Average volume (3 months)802,545
Market cap$312.4M
Dividend yield--
Data as of 2:32pm ET, 07/22/2014

Growth & Valuation

Earnings growth (last year)-1,300.00%
Earnings growth (this year)+47.86%
Earnings growth (next 5 years)+8.20%
Revenue growth (last year)+38.43%
P/E ratioNM
Price/Sales1.08
Price/Book2.78

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd+0.09+1.60%
XNCRXencor Inc+0.20+2.03%
CARACara Therapeutics In...-0.09-0.67%
GALEGalena Biopharma Inc+0.11+3.94%
Data as of 2:44pm ET, 07/22/2014

Financials

Next reporting dateAugust 12, 2014
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$84.9M
Annual profit (last year)-$25.6M
Net profit margin-30.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts